Recent

% | $
Quotes you view appear here for quick access.

Optimer Pharmaceuticals, AŞ Message Board

beameup_999 9 posts  |  Last Activity: Jul 30, 2015 1:36 PM Member since: Jul 1, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Cash Burn

    by beameup_999 Jul 30, 2015 8:44 AM
    beameup_999 beameup_999 Jul 30, 2015 1:36 PM Flag

    I agree, Phase III results are key to everything at this stage. They received a 20 million dollar milestone payment at the end of Phase II since it was successful, and although I have never seen the exact amount they would receive for successful Phase III results I'm sure it would be well in excess of the $20 million.( I believe that they will receive $260 million for all of the successful regulatory milestones and another quarter of a million, approximately, for the commercial milestones). I am invested heavily in this company and have been so for three years so I'm really pulling for their success. Outside of the finances and even more importantly I want these treatments to succeed for the medical breakthroughs involved with these horrific cancers.

  • Reply to

    Cash Burn

    by beameup_999 Jul 30, 2015 8:44 AM
    beameup_999 beameup_999 Jul 30, 2015 11:18 AM Flag

    That's exactly the question I am asking. If they are being reimbursed 70% of development costs why the $16 million cash burn in the 2nd quarter? Also the milestone payments are triggered by successful events such as FDA approval. They can't count on a large infusion of cash unless these milestones are met. So, once again, where is the operating cash coming from over the next two quarters?

  • beameup_999 by beameup_999 Jul 30, 2015 8:44 AM Flag

    THLD burned through 16 million dollars in the second quarter. Why so much? With $67 million left they will exhaust all their cash at this rate by the end of 2015. The news release does not address this issue:

    As of June 30, 2015 and March 31, 2015, Threshold had $67.0 million and $83.1 million in cash, cash equivalents and marketable securities, respectively. The net decrease of $16.1 million in cash, cash equivalents and marketable securities during the second quarter of 2015 was primarily due to the Company's operating cash requirements for the second quarter of 2015.

  • http://www.streetinsider.com/Analyst+Comments/Threshold+Pharmaceuticals+%28THLD%29+PT+Raised+to+$15+at+Piper+Jaffray/10188964.html

  • Reply to

    Senior Product Manager, Evofosfamide, Merck KGaA

    by yinzhiqi Jun 13, 2015 11:34 PM
    beameup_999 beameup_999 Jun 14, 2015 10:38 AM Flag

    Looks like THLD management are quite confident in their chances for approval of these two indications. They are obviously pleased with the way both Phase III trials are progressing.

  • Reply to

    Shopping?

    by oneshotcarson May 19, 2015 7:20 PM
    beameup_999 beameup_999 May 19, 2015 10:55 PM Flag

    Not necessary. They have 3.7 billion shares of stock in their Treasury Account which they have accumulated over the years though stock buybacks. At $87 per share currently they have a war chest of $322 billion. I think that just might be enough to by any company with the exception of Apple.

  • Reply to

    Does anyone ever wonder why

    by jk4763 May 13, 2015 2:47 PM
    beameup_999 beameup_999 May 15, 2015 2:44 PM Flag

    Yes really. My accounts are with Fidelity and you can not place a market order in the pre market. Try it some time and see what happens.

  • Reply to

    Does anyone ever wonder why

    by jk4763 May 13, 2015 2:47 PM
    beameup_999 beameup_999 May 13, 2015 4:41 PM Flag

    You cannot place a market order in pre market trading; only limit orders due to the thinness of the pre market.

  • Reply to

    Good job for all of us who bought over 4 yesterday.

    by jk4763 May 13, 2015 9:50 AM
    beameup_999 beameup_999 May 13, 2015 10:38 AM Flag

    The stock price has just about completed a round trip after the fast track news before the bell yesterday. The extensive number of shares traded cannot be accounted for by retail traders. It is simply too high. Therefore that just leaves the large hedge funds moving the stock price. In my view one or several deep pocked entities bought like crazy when the news broke yesterday morning and then shorted starting at the market open. They made money in each direction. None of this has anything to do with the fundamentals of THLD and has everything to do with trading for profit using other peoples money.

    The company has a very bright future which will be proven out as the two Phase 3 trials conclude. Hang in there if you can stomach the wild gyrations. For my part that's what I am doing.